ASH 2020: MDS and AML Updates for Patients | Aplastic Anemia & MDS International Foundation Return to top.

ASH 2020: MDS and AML Updates for Patients

Registration for this Webinar is now open. Please use the form below to register and receive a link to watch live on March 8, 2021.

Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Monday, March 8, 2021 - 3:00pm

Courtney D. DiNardo is an Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.  Dr. DiNardo is a clinical researcher with a specialized focus on prognostication and personalized therapeutics for patients with myeloid malignancies. She has completed formal training in epidemiology and biostatistics, with a Master's of Science in Clinical Epidemiology (2012). She is the principal investigator for multiple novel therapeutic agents currently in clinical trial and was involved in the clinical development of venetoclax for myeloid malignancies.  Dr. DiNardo is an internationally recognized researcher and clinician. 

Dr.DiNardio will provide a thorough review of the most important papers and studies presented at the 62nd American Society of Hematology Annual Meeting for patients with MDS and AML.  The presentation will be made in lay language so it is accessible for patients and families. 

Participants will have an opportunity to ask questions via the text chat window.  Those who are joining via telephone are invited to submit their questions to in advance of the webinar. 

Share with